Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

La Jolla Pharma preclinical data

December 19, 2005 8:00 AM UTC

In a rat model of stroke, LJP 1207 led to a marked reduction in the adhesion and infiltration of WBCs in blood vessels of brain after stroke and significantly reduced neurological damage. LJP 1207 is ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article